ClinicalTrials.Veeva

Menu

Distress in Crisis Situations During COVID-19

W

Wefight

Status

Completed

Conditions

Stress, Psychological

Treatments

Other: questionnaire assesment

Study type

Observational

Funder types

Industry

Identifiers

NCT04337047
WefightDistress20

Details and patient eligibility

About

There are many scales for screening or assessing the impact of a disease. These scales are generally used to diagnose or assess the severity of a disease and are carried out at the request of a physician by the patient. Conversational agents could make it possible to administer these questionnaires remotely, analyse them and use the results on a large scale, without prior medical intervention.

The main objective of this study is to quantify and qualify the distress of a large population in times of pandemic crisis.

Full description

The Peritraumatic Distress Inventory is the standard tool designed to assess distress in times of crisis. It consists of 13 questions.

Questions will be submitted to the participants from the Vik chatbot. Responses will be analysed and compared according to the demographics and pathologies encountered.

Enrollment

2,000 patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Age > 18 years old

    • Collection of the subject's non-opposition
    • Patient registration on Vik breast, Vik asthma, Vik migraine, Vik depression

Exclusion criteria

  • Patient unable to formulate non-opposition

Trial design

2,000 participants in 4 patient groups

Vik sein
Description:
Vik sein users
Treatment:
Other: questionnaire assesment
Vik asthme
Description:
Vik asthme users
Treatment:
Other: questionnaire assesment
Vik migraine
Description:
Vik migraine users
Treatment:
Other: questionnaire assesment
Vik depression
Description:
Vik depression users
Treatment:
Other: questionnaire assesment

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems